November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
December 30, 2025 - 23:48
OSS Sells Bressner Technology GmbH to Focus on Core MarketsIn a strategic move to enhance its focus on artificial intelligence (AI), machine learning (ML), and rugged edge computing, OSS has successfully completed the sale of Bressner Technology GmbH to...
December 30, 2025 - 14:00
Innovative Autoland Technology: A Game Changer in Aviation SafetyIn a significant advancement for aviation safety, a company based in Columbia is installing cutting-edge Autoland technology in aircraft. This revolutionary system is designed to enhance safety by...
December 29, 2025 - 20:33
Technology Trends of 2025: Insights for Architects and DesignersAs we step into 2025, several technology stories have emerged that are shaping the future of architecture and design. One of the most significant trends is the rapid proliferation of data centers....
December 29, 2025 - 13:03
2025 Marks Türkiye’s Rise in AI, Chip Strategy, and Influence in Global TechAs we approach 2025, Türkiye is positioning itself as a significant player in the global technology landscape, particularly in artificial intelligence (AI) and semiconductor development. The...